SUMMARY A total of 278 families of probands with Duchenne or Becker muscular dystrophy has been ascertained and offered genetic counselling. Linkage studies have been performed in these families using polymorphic DNA markers identifying loci linked to Duchenne and Becker muscular dystrophy. The clinical features of the probands are discussed: there was marked intrafamilial resemblance in the severity of the disease.
SUMMARY A total of 278 families of probands with Duchenne or Becker muscular dystrophy has been ascertained and offered genetic counselling. Linkage studies have been performed in these families using polymorphic DNA markers identifying loci linked to Duchenne and Becker muscular dystrophy. The clinical features of the probands are discussed: there was marked intrafamilial resemblance in the severity of the disease.
We estimate that a complete study of potential carriers in these families would require analysis of samples from approximately 1400 subjects. The results of linkage studies tended to move women's carrier risk estimates (based on CK and pedigree data) towards the extremes of the risk categories, providing a more definitive risk estimate for 81% of the women who were previously in the middle range of carrier risk probabilities. About 70% of the families had only one affected member. Linkage analysis altered carrier risk estimates in 95% of sisters and aunts of index cases, but only affected estimates of the mother's carrier risks in about 11% of isolated cases. Even where linkage studies were not helpful in elucidating carrier risks, information could usually be obtained for use in prenatal diagnosis if required.
We have assessed the attitudes to pregnancy and prenatal diagnosis of women at risk of being carriers of Duchenne or Becker muscular dystrophy and report 17 pregnancies in these women.
Duchenne muscular dystrophy (DMD) is the commonest and most severe type of dystrophy, inherited as an X linked recessive trait, with an incidence of about 1 in 3000 to 3500 males.' Becker muscular dystrophy (BMD) has a similar clinical pattern, but is milder than DMD and between six and 10 times less frequent. About half the males affected with DMD After electrophoresis and Southern blotting,12 filters were hybridised with appropriate 32p labelled DNA probes. Details of the loci tested, the probes used, and the heterozygote frequencies we observed are listed in table 1.13 Our strategy for the use of DNA probes for genetic counselling is as follows. For carrier detection, we screened for heterozygosity in a female, often the mother of the proband, using DNA markers in the following order: (1) pERT87-1 and pERT87-15, using an XmnI digest. (2) pXJ1l1 and pERT87-15, using a TaqI digest. (3) pERT87-8, using a BstXI digest. (4) pERT87-1, using BstNI and pERT87-8, using TaqI. When the woman was found to be heterozygous at a locus defined by one of these probes, this was used for analysis of her family.
Where flanking DNA markers were available, these were used preferentially. However, information using markers pXJ1-1 and pERT87 alone, with an estimated recombination fraction of 005 with the DMD and BMD loci,'5 made substantial differences to carrier risk estimates and was an efficient first screen. Screening of mothers wishing prenatal diagnosis was performed using the above markers, closely linked to DMD and BMD, and, in addition, the flanking markers 754 and 99*6 (using PstI), C7 (using EcoRV), and RC8 and L1.28 (using TaqI). Prenatal diagnoses were performed on DNA extracted from chorionic villus samples, using the closest marker (pXJ1-1 or pERT87) informative in the mother, and the two closest informative flanking markers.
Close flanking DNA markers (754, 99-6, and C7) were used preferentially for prenatal diagnosis, but where a woman presented late in pregnancy, prenatal advice was sometimes given using only the closely linked DNA probes pERT87 and pXJ1-1. Risk estimates and the possibility of inaccurate diagnosis using linked DNA markers were fully discussed with the families concerned, and decisions based on this advice were taken in full cognisance of the accuracy of the tests used in each case. of BMD cases, there were close female relatives, other than the mothers of the index cases, who might require genetic counselling.
Results
Of the 278 families seen personally in this study, 28% of 236 DMD index cases and 33% of 42 BMD cases were familial. In these families, the mean number of sibs of the DMD index cases was 1-59±1*34, and of the BMD index cases 1*84±1-46. (TABLE 4) None of the affected boys had dysmorphic features. Many boys with DMD had speech delay and required specific therapy for this. Mental retardation was found in 29% of DMD (table 4), but was not found in BMD, in accordance with previous experience. ' Of DMD boys with mental retardation, the average age at which ambulation was lost was 9-8±1-54 years old; in the group with normal IQ, this was 9-6±1-5 years old. Fifteen boys lost ambulation between the ages of 13 and 17 years, and were thus in the intermediate range between DMD and BMD.
In 18 pairs of brothers with DMD where intelligence was assessed, two pairs of affected boys both had mental retardation, while the 16 other pairs of brothers were all of normal intelligence. One family of three brothers (aged four years and younger) with muscular dystrophy all had speech and developmental delay. Their uncle, who had DMD, had an IQ of 50.
The clinical courses in two or more brothers, or more distant relatives, affected with DMD or BMD, were similar in 28 out of 30 families where detailed information was available.
In one family the uncle of the index case lost ambulation at 17 years of age and was alive, in a wheelchair, at 40 years of age, while the index case has a disorder more suggestive of DMD. However, as he is still only seven years old, his clinical course cannot be predicted. One pair of brothers had slightly discordant courses, in that one brother walked at 18 months and ceased to walk at 12 years, while the other walked at 12 months and ceased to walk at 16 years. Both had speech delay. Even in these cases, the discrepancies noted were not marked.
In an additional pair of brothers there was a striking difference in clinical symptoms, where one brother had classical DMD and ceased to walk at six and a half years, but the other had minimal proximal hip girdle weakness at 15 years, despite a high serum CK level. The mildly affected brother showed Although carrier risks to mothers of sporadic cases were not often greatly altered, linkage information was used to alter carrier risk estimates for sisters and aunts of the proband in these families. We used linkage calculations to alter the carrier risks of 53 sisters of affected boys. 22 In 15 families where linkage information indicated that the isolated affected boy had inherited his grandpaternal alleles linked to the DMD locus, the probability was increased that his disease had arisen as a new mutation, either in the grandpaternal or the maternal gamete. Consequently, the risk that the grandmother was a carrier was reduced and this, in turn, reduced the carrier risk estimates for 13 aunts. If, however, the affected boy had inherited the grandmaternal allele, as in nine of our families, the carrier risks to his aunts depended upon whether or not they had inherited from their mother the same allele as the mother of the affected boy. This was the case with seven aunts.
ATTITUDES TO PREGNANCY
Eleven women with carrier risks higher than 20% decided to have no further children (many opting for .V_ 1-sterilisation). This is probably an underestimate, because women making this decision do not often seek further genetic advice. Table 5 shows the decisions of women at risk of being carriers regarding pregnancies before the availability of prenatal diagnosis using linkage analysis.
Women perceiving their carrier risk to be low (below 10%) often elected to take the small risk of having an affected son without prenatal diagnosis, but most women with carrier risks above 30% elected to have fetal sexing and termination of pregnancy if the fetus was found to be male. Occasional exceptions are found: in our series two sisters at very high risk of being carriers both elected to continue their pregnancies without any form of prenatal diagnosis.
We have been asked for prenatal diagnosis or genetic counselling using linkage analysis in relation to 17 pregnancies in 15 women ( to complete our analysis of potential carriers in these families. We will therefore analyse in total about 1400 samples from 278 families. This gives an estimate of the workload involved in applying linkage to the analysis of X linked disorders for genetic counselling, which may be of value in planning further service development.
Our experience with genetic counselling suggests that linkage information provides further reassurance to women at low carrier risks, who may then undertake pregnancies without prenatal diagnosis. Women with higher carrier risks may still prefer to have pregnancies terminated if found to be male, but many may continue a pregnancy if prenatal tests show a male to have a 5% or lower risk of being affected. In the absence of disease specific prenatal tests, reproductive compensation after termination of male pregnancies probably had the dysgenic effect of increasing the numbers of carrier daughters born. Parents of affected boys appear to have had approximately the same number of children as the general population. The average size of the families we have studied, including the probands, was approximately 2-7. The Registrar General's statistics give family size as varying between 2-0 and 2*3 since 1928. However, our sample includes some sibships of older generations and a few families from outside the UK.
Because the current linkage estimates have error rates of the order of 2 to 5%, the most dramatic qualitative change in carrier risk estimates is seen in women with prior carrier risks in the low to intermediate range. These women had low, but not negligible, risks which they were unwilling to run. Dropping these risks by a factor of 20 altered their decisions about whether to undergo pregnancies without prenatal diagnosis. Linkage studies significantly alter the carrier risks of about 11% of mothers of isolated cases. In those families where DMD is associated with deletion of a probe site, more accurate counselling of mothers is sometimes possible.
As linkage information becomes more accurate, it is hoped that it will allow carrier women to have families without the fear of having an affected child and without the guilt consequent upon the termination of pregnancies which could have been normal. However, we remain unable to predict the two thirds of cases of DMD which present with no previous family history. We 
